from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3681c/whiB4

LFCtreatmentdescriptionclass of inhibitor

1.873

Amikacinug/mL Amikacintranslation

1.442

Cap5-10ug/mL Capreomycintranslation

2.416

Rox10-50 ug/mL Roxithromycintranslation

0.272

SM2-5 ug/mL Streptomycintranslation

3.086

Tet5-10 ug/mL Tetracyclinetranslation

-0.691

Rif0.2-5ug/mL Rifampicintranscription

-0.965

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.264

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.100

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.785

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.869

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.551

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.353

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.159

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.552

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.557

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.045

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.164

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.163

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.545

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.285

KCN5-20 ug/mL Potassium cyaniderespiration

-0.863

NaN30.2-2 mM Sodium aziderespiration

-0.096

Nigericin50 uM Nigericinrespiration

0.018

TRC10-150 ug/mL Triclosanrespiration

-0.239

TRZ10-25 ug/mL Thioridazinerespiration

2.396

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.859

menadione6-10 ug/mL Menadionerespiration

0.058

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.077

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.076

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.418

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.014

NRP_1Non-replicating persistence stage 1dosRassociated

-0.359

Amp0.2mg/mL AmpicillincellWall

-0.590

Cephalexin20-100 ug/mL CephalexincellWall

-0.220

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.438

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.594

EMB10-20 ug/mL EthambutolcellWall

-0.586

Eta12-40 ug/mL EthionamidecellWall

-0.031

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.356

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.558

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.509

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.181

BZA0.12 mg/mL BenzamidearomaticAmides

-0.237

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.036

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.375

H2O24 mM hydrogen peroxideDNAdamaging

-0.348

Levo10 ug/mL LevofloxacinDNAdamaging

-0.573

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.940

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.502

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.149

UVUV-irradiationDNAdamaging

1.918

ARP41-4 ug/mL Antitubercular compound ARP4?

0.243

Antimycin12.5-50 ug/mL Antimycin A?

-0.263

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.035

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.370

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.324

PA8240.2-2 ug/mL PA-824?

0.529

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.459

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.015

Verapamil50 uM Verapamil?

-0.445

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.149

methoxatin10-20 ug/mL Methoxatin?